• 学术搜索
  • 科研智能体
    • Research Labs
    • AI 阅读
    • AI 文库
    • 深度研究
    • 学者亮点
  • 学术资源
    • AI2000
    • 期刊/会议
    • 学者库
    • 学术API
      MCP&Skill
    • 溯源树
    • 数据集
  • 知识沉淀
    • 学术空间
订阅小程序
旧版功能
aminer vip
开通会员低至0.73元/天
一次搞定AI科研
立即登录
  • English
  • 联系方式
    Translational Genomics Research Institute

    Translational Genomics Research Institute

    EST. 2002
    1,485论文总数
    9.1万引用总数

    论文量&引用量时间轴

    机构学者

    论文(1485)

    年份
    起
    –
    止
    排序
    1A Plasma Protein Signature for Cerebral Amyloid Angiopathy
    Alpana Singh,Marisa N. Denkinger,Antoine Leuzy,Kari Dieckhoff, Jame Liu, Taina M. Marques, Edwin Monuki, Craig Stark,Joshua D. Grill,Christy Hom, David Sultzer,Eric Doran,

    Cerebral amyloid angiopathy (CAA) is a cerebrovascular disorder characterized by the deposition of amyloid-β (Aβ) in the walls of leptomeningeal and cortical blood vessels that increases risk of intracerebral hemorrhages and progressive cognitive decline. More than 90

    2026Acta Neuropathologica(2026)引用:73
    引用
    AI阅读
    加入学术空间
    2Haplotype-resolved Genome Assemblies of BJ and IMR-90 Human Fibroblast Cell Lines Reveal Extensive Structural Variation and Enable Reanalysis of Historical Sequencing Data
    T Rhyker Ranallo-Benavidez, Yue Hao, Emilia Volpe, Maryam Jehangir, Noelle Fukushima,Zachary D Stephens, Ogechukwu Mbegbu,Matteo T Ungaro,Rebecca Reiman, Jessica Molnar, Danyael Murphy, Dorothy Marie Paredes,

    We present chromosome-level, phased diploid genome assemblies of two widely used human fibroblast cell lines: BJ (46,XY) and IMR-90 (46,XX). Using Oxford Nanopore, PacBio HiFi, and Hi-C sequencing data, we generated assemblies spanning 5.9 and 6.0 Gbp with diploid quality values exceeding QV 60. To validate structural integrity, we developed KaryoScope, an alignment-free tool for generating computational karyograms from k-mer feature databases. We identify >50 000 structural variants relative to T2T-CHM13v2.0, the majority of which are heterozygous and cell-line-specific. Combining reference-based and de novo gene annotation, we uncover a previously unreported 1 Mbp homozygous duplication at the 16p11.2 locus in BJ, demonstrating that even karyotypically normal cell lines can harbor clinically relevant submicroscopic rearrangements. We show that mapping publicly available short-read, RNA-seq, and ChIP-seq data to sample-matched diploid assemblies substantially improves read alignment and enables haplotype phasing of 23%-28% of short reads. The BJ and IMR-90 assemblies and associated variant calls are publicly available as a resource for the research community.

    2026Nucleic acids research(2026)引用:1
    引用
    AI阅读
    加入学术空间
    3IMMREP25: Unseen Peptides
    Eve Richardson, Yannick Jurriaan Maria Aarts, John A. Altin, Coos A. B. Baakman,Philip Bradley,Binbin Chen, Joakim Clifford, Manjima Dhar, Danielle Diepenbroek, Ethan Fast,Ragul Gowthaman, Jieling He,

    T cell receptors (TCRs) can bind to peptides presented by MHC molecules (pMHC) as a first step to trigger a T cell response. Reliable approaches to predict TCR:pMHC binding would have broad applications in clinical diagnostics, therapeutics, and the fundamental understanding of molecular interactions. IMMREP is a community organized series of prediction contests that asks participants to predict TCR:pMHC binding on unpublished datasets. Previous iterations in 2022 and 2023 showed multiple approaches can predict TCR-pMHC binding with significant accuracy (median AUC\_0.1≥0.7) for peptides where experimental data is available (“seen” peptides). In contrast, models did not outperform random guessing for peptides that have no such data available (“unseen” peptides). Here we report on the results of IMMREP25, which focused solely on unseen peptides in order to evaluate the cutting edge of the field. We received 126 named submissions predicting the specificity of 1,000 TCRs against twenty unseen peptides restricted by one of two MHC molecules (HLA-A*02:01 and HLA-B*40:01). The best performing methods showed a macro-AUC\_0.1 of 0.60, significantly better than random, demonstrating significant advances in the field. The top performing methods incorporated structural modeling into their approach, indicating that especially for ‘unseen’ peptides, a structural understanding aids in the prediction of TCR:pMHC interactions. The results from this benchmark highlight the significant challenges remaining for TCR:pMHC predictions and will inform future method development. ### Competing Interest Statement The authors have declared no competing interest.

    2026引用:1
    引用
    AI阅读
    加入学术空间
    4Autophagy Activators Normalize Aberrant Tau Proteostasis and Rescue Synapses in Human Familial Alzheimer's Disease Ipsc‐derived Cortical Organoids
    Sergio R Labra, Jadon Compher, Akhil Prabhavalkar, Mireya Almaraz, Claudia Cedeño Kwong, Christine Baal,Maria Talantova,Nima Dolatabadi, Julian Piña-Sanz, Yubo Wang,Leonard Yoon,Swagata Ghatak,

    ABSTRACT Alzheimer's disease (AD) is the leading cause of dementia worldwide. Nevertheless, its cellular and molecular mechanisms remain incompletely understood, partially due to inadequate disease models. To illuminate early changes in AD, we developed a cerebrocortical organoid (CO) model with improved methodology. Our COs produce excitatory and inhibitory neurons alongside glia, utilizing established isogenic wild‐type and diseased human induced pluripotent stem cells (hiPSCs) carrying heterozygous familial AD mutations in PSEN1ΔE9/WT, PSEN1M146V/WT, or APPSwe/WT. In addition to amyloid‐beta (Aβ) accumulation, the AD COs display time‐progressive loss of monomeric Tau, and accumulation of aggregated high‐molecular‐weight (HMW) phospho(p)‐Tau species (pT181 and pT217). They also exhibit neuronal hyperexcitability reminiscent of early electroencephalography (EEG) clinical findings and synapse loss in AD patient brains. Single‐cell RNA‐sequencing analyses of AD and WT control COs reveal significant divergent molecular abnormalities in excitatory vs. inhibitory neurons, with several pathways being upregulated in one while downregulated in the other, providing insight into AD phenotypes. Finally, we show that chronic dosing with autophagy activators, including a novel mTOR inhibitor‐independent drug candidate, prevents pathologic Aβ and HMW p‐Tau accumulation, normalizes hyperexcitability, and rescues synaptic loss in AD COs. Collectively, our results demonstrate this CO model as a useful platform for assessing early features of familial AD pathogenesis and for testing small‐molecule candidate therapeutics.

    2026Advanced science (Weinheim, Baden-Wurttemberg, Germany)(2026)引用:1
    引用
    AI阅读
    加入学术空间
    5Proteogenomic Features Define Subtypes of Mantle Cell Lymphoma
    Yuting Yan, Weihao Chen, Xinzhou Ge,Jian Sun, Lei Yu, Krystine Garcia-Mansfield, Xinyi Zhang,Ying Yu,Wenjie Xiong,Dehui Zou,Gang An,Zhenyu Jia,

    Abstract Mantle cell lymphoma (MCL) is a biologically heterogeneous B-cell malignancy. Although genomics and transcriptomics have delineated parts of the MCL disease spectrum, proteomics remains largely unexplored. Here, we conducted a comprehensive proteogenomic analysis integrating genomics, transcriptomics, and proteomics on peripheral blood samples from 27 patients with MCL and 4 healthy donors to investigate the translational and posttranslational dimensions of MCL. Our study identified 1296 downregulated and 468 upregulated proteins in MCL cells. The splicing pathways were significantly upregulated at both the mRNA and protein levels, suggesting a critical role for aberrant RNA splicing in MCL pathogenesis. Integration of proteomic data with genetic aberrations revealed immunoglobulin heavy chain variable mutational status and CCND1 mutation are associated with distinctive transcriptomic and proteomic profiles, which correspond to significant differences in clinical outcomes. A multiomics molecular stratification model incorporating proteomic data showed superior predictive power for patient survival compared with single-omics models (concordance index, 0.83 vs 0.74). This study provides, to our knowledge, the first comprehensive proteogenomic profile of MCL, offering novel insights into its molecular mechanisms and clinical behavior. The identification of molecular subtypes and prognostic protein signatures underscores the potential of proteomics to guide precision medicine strategies for MCL.

    2026Blood advances(2026)引用:1
    引用
    AI阅读
    加入学术空间
    立即登录,查看全部 1485 篇论文

    合作机构(100)

    温纳贝戈医学中心合作论文 107
    亚利桑那大学合作论文 82
    华盛顿大学合作论文 75
    亚利桑那州立大学合作论文 73
    加州大学合作论文 68
    希望之城国家医疗中心合作论文 64
    美国国家卫生研究院合作论文 59
    密歇根大学合作论文 50
    埃默里大学合作论文 49
    约翰斯·霍普金斯大学合作论文 47

    机构统计